Review
doi: 10.1128/CDLI.8.4.671-677.2001.
Immunological effects of interleukin-2 therapy in human immunodeficiency virus-positive subjects
Affiliations
- PMID: 11427409
- PMCID: PMC96125
- DOI: 10.1128/CDLI.8.4.671-677.2001
Item in Clipboard
Review
Immunological effects of interleukin-2 therapy in human immunodeficiency virus-positive subjects
Clin Diagn Lab Immunol.
2001 Jul.
No abstract available
Similar articles
-
Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy.Eur J Immunol. 2001 May;31(5):1351-60. doi: 10.1002/1521-4141(200105)31:5<1351::AID-IMMU1351>3.0.CO;2-9. Eur J Immunol. 2001. PMID: 11465092 Clinical Trial.
-
A look at HIV immune research. Interview by Alan Huff.Res Initiat Treat Action. 2000 Sep;6(3):30-3. Res Initiat Treat Action. 2000. PMID: 11708165 No abstract available.
-
Decreased apoptosis despite severe CD4 depletion in the thymus of a human immunodeficiency virus-1 infected child.Klin Padiatr. 2011 Jul;223(4):246-8. doi: 10.1055/s-0030-1270514. Epub 2011 Jan 26. Klin Padiatr. 2011. PMID: 21271506
-
The dynamics of CD4+ T-cell depletion in HIV disease.Nature. 2001 Apr 19;410(6831):974-9. doi: 10.1038/35073648. Nature. 2001. PMID: 11309627 Review.
-
The role of naïve T-cells in HIV-1 pathogenesis: an emerging key player.Clin Immunol. 2011 Dec;141(3):253-67. doi: 10.1016/j.clim.2011.09.002. Epub 2011 Sep 17. Clin Immunol. 2011. PMID: 21996455 Review.
Cited by
-
Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System.Front Immunol. 2020 Dec 15;11:596631. doi: 10.3389/fimmu.2020.596631. eCollection 2020. Front Immunol. 2020. PMID: 33384690 Free PMC article. Review.
-
CD8 apoptosis may be a predictor of T cell number normalization after immune reconstitution in HIV.J Transl Med. 2007 Jan 30;5:9. doi: 10.1186/1479-5876-5-9. J Transl Med. 2007. PMID: 17263884 Free PMC article.
-
Thymic Exhaustion and Increased Immune Activation Are the Main Mechanisms Involved in Impaired Immunological Recovery of HIV-Positive Patients under ART.Viruses. 2023 Feb 5;15(2):440. doi: 10.3390/v15020440. Viruses. 2023. PMID: 36851655 Free PMC article.
-
Low-dose interleukin-2 alleviates dextran sodium sulfate-induced colitis in mice by recovering intestinal integrity and inhibiting AKT-dependent pathways.Theranostics. 2020 Apr 6;10(11):5048-5063. doi: 10.7150/thno.41534. eCollection 2020. Theranostics. 2020. PMID: 32308767 Free PMC article.
-
Distinctive in vitro effects of T-cell growth cytokines on cytomegalovirus-stimulated T-cell responses of HIV-infected HAART recipients.Virology. 2008 Aug 15;378(1):48-57. doi: 10.1016/j.virol.2008.05.018. Epub 2008 Jun 24. Virology. 2008. PMID: 18572217 Free PMC article.
References
-
- Adachi Y, Oyazu N, Than S, McCloskey T, Pahwa S. IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection. J Immunol. 1996;157:4184–4193. - PubMed
-
- Amiesen J C. Programmed cell death and AIDS: From hypothesis to experiment. Immunol Today. 1992;13:388–391. - PubMed
-
- Arno A, Ruiz L, Juan M, Jou A, Balague M, Zayat M, Marfil S, Martinez-Picado J, Martinez M, Romeu J, Pujol-Borrell R, Lane H, Clotet B. Efficacy of low-dose sc IL-2 to treat advanced HIV-1 in persons with ≤250/μl CD4 T cells and undetectable plasma virus load. J Infect Dis. 1999;180:56–60. - PubMed
-
- Atkins M, Mier J, Parkinson D, Gould J, Berkman E, Kaplan M. Hypothyroidism after treatment with IL-2 and LAK cells. N Engl J Med. 1988;318:1557–1562. - PubMed
-
- Blanco J, Cabrera C, Jou A, Ruiz L, Clotet B, Estè J. Chemokine and chemokine receptor expression after combined anti-HIV-1 interleukin-2 therapy. AIDS. 1999;13:547–555. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
